๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Colorectal Cancer Metastatic

Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. NCT07044921Phase 21 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC NCT06553885Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Enfortumab Vedotin Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site๐Ÿ“ Hangzhou Weijia Fang, MD ยท Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer NCT06008119Phase 31 site๐Ÿ“ Beijing Shanghai Kechow Pharma, Inc. ยท Tests: Tunlametinib plus Vemurafenib, Doublets Chemotherapy ยฑ Bevacizumab or Doublets Chemotherapy ยฑ Cetuximab Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease NCT06607458Phase 220 sites๐Ÿ“ Duarte๐Ÿ“ Santa Monica๐Ÿ“ Miami Delcath Systems Inc. ยท Tests: Melphalan/HDS Followed by Consolidation Treatment with Trifluridine-tipiracil plus Bevacizumab, Trifluridine-tipiracil โ€ฆ Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer NCT07026110NA1 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4, [18F]F-RESCA-EPCD6 Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer NCT06509126Phase 31 site๐Ÿ“ Naples National Cancer Institute, Naples ยท Tests: Panitumumab, Irinotecan, 5-fluorouracil, L-folinic acid Advanced Therapies for Liver Metastases NCT04622423n/a1 site๐Ÿ“ Milan IRCCS San Raffaele Sacituzumab Govitecan in Metastatic Colorectal Cancer NCT06243393Phase 2, Phase 31 site๐Ÿ“ Heidelberg University Hospital Heidelberg ยท Tests: Sacituzumab Govitecan (SG), Physicians Choice (PhC). Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases NCT04520737NA1 site๐Ÿ“ Tarragona Institut Investigacio Sanitaria Pere Virgili ยท Tests: Physical Prehabilitation AB122 Platform Study NCT04999761Phase 19 sites๐Ÿ“ Aichi๐Ÿ“ Chiba๐Ÿ“ Ehime Taiho Pharmaceutical Co., Ltd. ยท Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 A Study on the Efficacy and Safety of Multi-mode Ablation Combined With Systemic Therapy in the Treatment of CRCLM NCT06590259Phase 21 site๐Ÿ“ Shanghai Shanghai 6th People's Hospital ยท Tests: Multi-mode tumor treatment system, Sintilimab+mFOLFOX6 or FOLFIRI+bevacizumab or cetuximab Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors NCT06974110Phase 115 sites๐Ÿ“ Phoenix๐Ÿ“ San Diego๐Ÿ“ Tampa MOMA Therapeutics ยท Tests: MOMA-341, Irinotecan, Immunotherapy Colorectal Metastasis Prevention International Trial 2 NCT03919461Phase 26 sites๐Ÿ“ Afula๐Ÿ“ Haifa๐Ÿ“ Petah Tikva Assaf-Harofeh Medical Center ยท Tests: Propranolol and etodolac, Placebo AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond NCT06678919n/a7 sites๐Ÿ“ Linz๐Ÿ“ Linz๐Ÿ“ Rankweil Arbeitsgemeinschaft medikamentoese Tumortherapie A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Whittier Daiichi Sankyo ยท Tests: Ifinatamab deruxtecan Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites๐Ÿ“ San Francisco๐Ÿ“ Walnut Creek University of California, San Francisco ยท Tests: Radiation Therapy (RT) Comparing Efficacy and Safety of Enlituoยฎ Versus Erbituxยฎ Plus FOLFOX in Locally Advanced/Metastatic Colorectal Cancer With RAS/BRAF Wild-type and MSS/pMMR Status. NCT07595276Phase 31 site๐Ÿ“ Guangzhou Taizhou Mabtech Pharmaceutical Co.,Ltd ยท Tests: Enlituoยฎ, Erbituxยฎ DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer NCT06275958Phase 336 sites๐Ÿ“ 's-Hertogenbosch๐Ÿ“ Alkmaar๐Ÿ“ Amstelveen Leiden University Medical Center ยท Tests: Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%)โ€ฆ Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy NCT07201519Phase 21 site๐Ÿ“ Lexington Michael J Cavnar, MD ยท Tests: Hepatic Artery Infusion Pump (HAIP), Standard Treatment, Community Treatment, Systemic Chemotherapy Standard of Care, Sโ€ฆ MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases NCT06208397n/a1 site๐Ÿ“ Shenyang Shengjing Hospital ยท Tests: Magnetic Resonance Elastography and routine MRI FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colorectal Cancer With Liver Metastasis NCT06801665Phase 21 site๐Ÿ“ Changzhou Hua Jiang ยท Tests: FMT+QL1706+Bevacizumab+XELOX A Study of 2nd-line FOLFIRI ยฑ Bevacizumab vs. Irinotecan ยฑ Bevacizumab in mCRC NCT03303495Phase 31 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Bevacizumab, CPT-11, 5-FU Bolus, 5-FU Infusion, l-LV (dl-LV) PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM NCT06788171Phase 21 site๐Ÿ“ Fuzhou Fujian Cancer Hospital ยท Tests: Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy, Bevacizumab, Capecitabine, Oxaliplatin, Sintilimab A Dose-Expansion Trial of Intravenous HNF4ฮฑ srRNA for Unresectable or Metastatic Colorectal Cancer NCT07050394EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: CD-GA-102 Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer NCT04743102NA1 site๐Ÿ“ Beijing Beijing Chao Yang Hospital ยท Tests: multi-points and full-thickness Biopsy, traditional cCR Secondary Care Colorectal Cancer Pathway Review NCT07430527n/a2 sites๐Ÿ“ Edinburgh๐Ÿ“ Edinburgh University of Edinburgh ยท Tests: Faecal Immunohistochemical test TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases NCT07607873NA1 site๐Ÿ“ Milan Niguarda Hospital ยท Tests: Liver Transplantation, Liver Resection plus Ablation Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer NCT06184698Phase 21 site๐Ÿ“ Shijiazhuang Hebei Medical University Fourth Hospital ยท Tests: liposomal irinotecan, 5-FU, LV, Bevacizumab A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Sarasota๐Ÿ“ St Louis Angiex, Inc. ยท Tests: AGX101
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy